Latest Platform Launch News

Nick Scali Limited reported a robust 1H FY25 with revenue growth and profits exceeding guidance, despite ongoing UK market disruptions and restructuring costs.

LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.

Praemium Limited reports a solid Q2 FY25 performance, with Funds Under Administration rising 4% to $30.2 billion and net inflows surging to $371 million, driven by strong momentum in its SMA and Powerwrap platforms.